| Biomarker ID | 1330 |
| PMID | 24494028 |
| Year | 2014 |
| Biomarker | TP53INP2 |
| Biomarker Basis | Expression Based |
| Biomolecule | Protein |
| Source | Urine |
| Subjects | Humans |
| Regulation | Differentially Expressed |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | Pathways include: CDK18 human kinase ARCHS4 coexpression, NRBP2 human kinase ARCHS4 coexpression, STK39 human kinase ARCHS4 coexpression, ACVR1B human kinase ARCHS4 coexpression, AATK human kinase ARCHS4 coexpression |
| Experiment | Prostate Cancer Vs Benign Prostatic Hyperplasia |
| Type of Biomarker | Diagnostic |
| Cohort | 8 PCa patients, 12 BPH patients and 10 healthy males were selected for analysis |
| Senstivity | 76% |
| Specificity | 7% |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | NA |
| Method Used | qRT-PCR |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Validated on independent patient dataset |
| Technical Name | NA |